CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularization.
Ashraf S, Bell S, O'Leary C, Canning P, Micu I, Fernandez JA, O'Hare M, Barabas P, McCauley H, Brazil DP, Stitt AW, McGeown JG, Curtis TM.
Ashraf S, et al. Among authors: curtis tm.
JCI Insight. 2019 Mar 21;4(6):e122442. doi: 10.1172/jci.insight.122442. eCollection 2019 Mar 21.
JCI Insight. 2019.
PMID: 30721154
Free PMC article.